Loading clinical trials...
Loading clinical trials...
TRANSFIX - Zenith® TX2® Low Profile Endovascular Graft for Blunt Thoracic Aortic Injury
The TRANSFIX study is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® TX2® Low Profile Endovascular Graft for treatment of Blunt Thoracic Aortic Injury.
Age
16 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Keck Hospital of USC
Los Angeles, California, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
University of Miami School of Medicine
Miami, Florida, United States
Grady Memorial Hospital
Atlanta, Georgia, United States
University of Louisville
Louisville, Kentucky, United States
University of Maryland Medical Center
Baltimore, Maryland, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
Mercy Hospital St. Louis
St Louis, Missouri, United States
Cooper University Hospital
Camden, New Jersey, United States
Start Date
January 23, 2013
Primary Completion Date
June 1, 2014
Completion Date
July 29, 2019
Last Updated
November 18, 2020
50
ACTUAL participants
Zenith® TX2® Low Profile Endovascular Graft
DEVICE
Lead Sponsor
Cook Research Incorporated
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07362901